Loading

Accelerating the Globalization of Cell and Gene Therapies

June 04, 2024
Breakout Session
Cell and Gene Therapy and Genome Editing
31AB
While cell and gene therapies (CGTs) have had tremendous success in the western world, particularly in the US and EU, its benefits have yet to reach the shores of several other parts of the world including Asia, Middle East, Australia and Africa, where patients are desperately in need. Manufacturing and supply chain have been one of the major hurdles that limit access of these life-saving therapies in these geographies. This panel will include experts who are reshaping the manufacturing and supply paradigm in international geographies and paving the path for making CGTs accessible for patients across the globe.
Speakers
Jennifer Rabin
Specialist Leader
Deloitte Consulting LLP
Speakers
Shahrukh Hashmi
Faculty
Mayo Clinic
Peter Holman
VP of Quality
Arsenal Bio
Robert Hughes
Global Head of Technical Operations
Galapagos
Sumant Ramachandra
CEO
Impact Bio
Kristen Sudol
Vein to Vein Supply Chain
Johnson & Johnson
Xiaoxi (Sofie) Wei, PhD
CEO & Co-Founder
X-Therma
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS